General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-01-04 | 2023-09 | 0 | N/A | N/A | N/A |
2023-10-05 | 2023-06 | 0 | N/A | N/A | N/A |
2023-07-06 | 2023-03 | 0 | N/A | N/A | N/A |
2023-04-06 | 2022-12 | 0 | N/A | N/A | N/A |
2022-11-10 | 2022-09 | 0 | -0.59 | N/A | N/A |
2022-08-11 | 2022-06 | 0 | -0.67 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2020-11-25 | Ladenburg Thalmann | Upgrade | Neutral | Buy |
2020-11-25 | Ladenburg Thalmann | Downgrade | Buy | Neutral |
2020-11-25 | Maxim Group | Downgrade | Buy | Hold |
2020-11-25 | Mizuho | Downgrade | Buy | Underperform |
2020-11-25 | Mizuho Securities | Downgrade | Buy | Underperform |
2020-11-25 | Stifel Nicolaus | Downgrade | Buy | Hold |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2019-01-28 | ATKINSON JAMES G | President | 964.61K | Stock Award(Grant) |
2019-03-31 | BASTA STEVEN L | Director | 24.20K | Stock Award(Grant) |
2018-07-01 | BUSH LORI H | Director | 6.53K | Stock Award(Grant) |
2019-01-28 | DURBIN SCOTT C | Chief Executive Officer | 73.82K | Stock Award(Grant) |
2019-09-30 | GOLDMAN SACHS GROUP INC. | Unknown | 0.00 | Sale |
2018-12-30 | JANNEY DANIEL SPENCER | Director | 1.44M | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-12-30 | Blackrock Inc. | 244.23K | 23.93K | 2.28% |
2022-12-30 | Vanguard Group, Inc. (The) | 60.34K | 5.91K | 0.56% |
2022-12-30 | State Street Corporation | 55.37K | 5.43K | 0.52% |
2022-12-30 | Geode Capital Management, LLC | 51.36K | 5.03K | 0.48% |
2022-12-30 | Renaissance Technologies, LLC | 32.00K | 3.14K | 0.30% |
2022-12-30 | Northern Trust Corporation | 17.07K | 1.67K | 0.16% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-09-29 | Vanguard Extended Market Index Fund | 114.01K | 11.17K | 1.06% |
2022-11-29 | Fidelity Extended Market Index Fund | 41.62K | 4.08K | 0.39% |
2022-11-29 | Fidelity Series Total Market Index Fund | 5.48K | 537.00 | 0.05% |
2022-11-29 | Fidelity NASDAQ Composite Index Fund | 3.78K | 370.00 | 0.04% |
Split | Date |
---|---|
1 : 10 | 2020-12-02 |
1 : 100 | 2019-09-19 |
1 : 8 | 2016-04-18 |
1 : 100 | 2014-09-25 |
$VIVE Boooooom. Lift off.
$VIVE Itβs coming back to rally boys and girls.
43 coming up..
Hold your shares here..
Loading the boat letβs rock and roll...
Weeeeeeeeeeeeeeeee
Now the big rise?
Is this thing just going to keep going down every day until earnings on 9/16? $VIVE
Downgrade to hold happened on july 22 for $VIVE
Not much selling pressure. More buyers coming in.
$VIVE
This ticker did not move with a FDA clearance news. Very strange . What are we expecting in July ?
We need another strong catalyst
This one goes down on news and up without news
Pumpers , we need your help even after strong technicals and PR/ FDA approval and 8k filing on distribution agreement
Just the timing of approval after the $PTN is keeping it from flying , this will run soon
No rockets here . Patience pays
It will gap up to. 45 at open
FDA approval and distribution agreement with a co in middle east . Strong buy recommendation from analyst . We will see $2 this week ???
This is going to rip AH
Added 5k at .41 . Thanks you penny flippers